resveratrol has been researched along with Liver Diseases in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 6 (20.69) | 2.80 |
| Authors | Studies |
|---|---|
| Bokov, D; Chupradit, S; Hakimizadeh, E; Heidari, M; Zamanian, MY | 1 |
| Azarpira, N; Dastghaib, S; Karima, S; Koohpeyma, F; Mokarram, P; Noori, S; Rezaei, R; Totonchi, H | 1 |
| Chen, MC; Chen, RJ; Chen, TS; Huang, CY; Lai, CH; Lin, YM; PadmaViswanadha, V; Pai, PY; Shen, CY; Yang, CK | 1 |
| Annunziata, M; Dallio, M; Federico, A; Izzo, C; Masarone, M; Melara, G; Persico, M; Sciorio, R | 1 |
| Chang, SKC; Chen, YW; Chiu, MH; Hou, CY; Liao, JX; Shih, MK; Tain, YL; Yeh, YT | 1 |
| Batcik, Ş; Bilen, A; Mercantepe, F; Tümkaya, L; Yilmaz, A | 1 |
| Szkudelska, K; Szkudelski, T | 1 |
| Cui, Z; Wang, S; Xiang, H; Yu, S; Zhou, J; Zhou, X | 1 |
| Chang, RL; Chen, RJ; Chen, TS; Day, CH; Huang, CY; Ju, DT; Lin, YC; Viswanadha, VP; Yao, CH; Yeh, YL | 1 |
| Cha, HY; Kang, MG; Kim, YM; Lee, HJ; Lim, Y; Yang, SJ | 1 |
| Khafaga, AF; Noreldin, AE; Taha, AE | 1 |
| Gurocak, S; Karabulut, AB; Karabulut, E; Karadag, N; Ozgor, D; Ozkeles, N | 1 |
| Chen, Y; Cheng, B; Cheng, Y; Gao, L; Jiang, H; Jiang, J; Shan, A; Yu, H; Zhang, Z | 1 |
| Conte, E; Fagone, E; Fruciano, M; Gili, E; Iemmolo, M; Vancheri, C | 1 |
| Das, SK; DesAulniers, J; Dyck, JR; Kassiri, Z; Oudit, GY | 1 |
| Caporaso, N; Fogliano, V; Milani, S; Morisco, F; Ottanelli, B; Vitaglione, P | 1 |
| Buyukbayram, H; Gedik, E; Girgin, S; Obay, BD; Ozturk, H | 1 |
| Cetinel, S; Ekşioğlu-Demiralp, E; Erzik, C; Mayadağli, A; Ozyurt, H; Sehirli, O; Sener, G; Toklu, HZ; Velioğlu-Oğünç, A; Yeğen, BC | 1 |
| Chiang, CM; Fang, S; Kanamaluru, D; Kemper, JK; Miao, J; Ponugoti, B; Tsang, S; Veenstra, TD; Wu, SY; Xiao, Z | 1 |
| Bishayee, A; Darvesh, AS; McGory, R; Politis, T | 1 |
| Das, A | 1 |
| Badary, O; Hamadi, N; Hassan, MH; Khalifi-Touhami, F; Mansour, A | 1 |
| Hussein, MA | 1 |
| Liu, L; Liu, T; Shen, X; Wang, R; Zhao, G | 1 |
| Caporaso, N; Fogliano, V; Morisco, F; Vitaglione, P | 1 |
| Arenas, JI; Bidaurrazaga, J; Bujanda, L; de Luco, MF; Echenique-Elizondo, M; García-Barcina, M; Gutiérrez-de Juan, V; Gutiérrez-Stampa, M; Hijona, E; Larzabal, M; Sarasqueta, C | 1 |
| Bujanda, L; García-Barcina, M | 1 |
| Muriel, P; Perez-Alvarez, V; Rivera, H; Shibayama, M; Tsutsumi, V | 1 |
| Muriel, P; Rivera-Espinoza, Y | 1 |
6 review(s) available for resveratrol and Liver Diseases
| Article | Year |
|---|---|
Hepatoprotective and therapeutic effects of resveratrol: A focus on anti-inflammatory and antioxidative activities.
Topics: Anti-Inflammatory Agents; Antioxidants; Glutathione; Humans; Liver; Liver Diseases; Oxidative Stress; Phosphatidylinositol 3-Kinases; Resveratrol | 2022 |
The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials.
Topics: Antioxidants; Humans; In Vitro Techniques; Liver Diseases; Resveratrol | 2021 |
Potential of resveratrol in mitigating metabolic disturbances induced by ethanol.
Topics: Animals; Antioxidants; Ethanol; Humans; Lipid Metabolism; Liver; Liver Diseases; Metabolic Diseases; Resveratrol; Stilbenes | 2018 |
Anti-inflammatory and antifibrotic effects of resveratrol in the lung.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Disease Models, Animal; Fibrosis; Humans; Inflammation; Liver Diseases; Lung; Mice; Pulmonary Disease, Chronic Obstructive; Resveratrol; Stilbenes | 2015 |
Dietary antioxidant compounds and liver health.
Topics: alpha-Tocopherol; Animals; Antioxidants; beta Carotene; Biological Availability; Carotenoids; Diet; Flavonoids; Health Promotion; Humans; Liver; Liver Diseases; Lycopene; Phenols; Polyphenols; Quercetin; Resveratrol; Stilbenes; Vitamin A | 2004 |
Beneficial drugs for liver diseases.
Topics: Adrenal Cortex Hormones; Animals; Colchicine; Curcumin; Disease Models, Animal; Drug Combinations; Glycyrrhizic Acid; Humans; Interferons; Liver Diseases; Nitric Oxide; Plant Extracts; Resveratrol; S-Adenosylmethionine; Silymarin; Stilbenes; Thalidomide | 2008 |
23 other study(ies) available for resveratrol and Liver Diseases
| Article | Year |
|---|---|
Resveratrol promotes liver cell survival in mice liver-induced ischemia-reperfusion through unfolded protein response: a possible approach in liver transplantation.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Endoribonucleases; Ischemia; Liver; Liver Diseases; Liver Transplantation; Mice; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Reperfusion; Reperfusion Injury; Resveratrol | 2022 |
Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy.
Topics: Adipose Tissue; Administration, Oral; Animals; Antioxidants; Diabetes Mellitus, Experimental; Liver; Liver Diseases; Male; Rats; Rats, Wistar; Resveratrol; Stem Cell Transplantation; Stem Cells; Thiobarbituric Acid Reactive Substances | 2020 |
Resveratrol Butyrate Esters Inhibit BPA-Induced Liver Damage in Male Offspring Rats by Modulating Antioxidant Capacity and Gut Microbiota.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Butyrates; Esters; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Liver; Liver Diseases; Male; Phenols; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Resveratrol | 2021 |
The hepatoprotective potential of resveratrol in an experimental model of ruptured abdominal aortic aneurysm via oxidative stress and apoptosis.
Topics: Animals; Aortic Aneurysm, Abdominal; Aortic Rupture; Apoptosis; Disease Models, Animal; Liver Diseases; Male; Oxidative Stress; Rats; Resveratrol | 2021 |
Resveratrol Reduced Liver Damage After Liver Resection in a Rat Model by Upregulating Sirtuin 1 (SIRT1) and Inhibiting the Acetylation of High Mobility Group Box 1 (HMGB1).
Topics: Acetylation; Animals; Apoptosis; Disease Models, Animal; Hep G2 Cells; Hepatectomy; Hepatocytes; HMGB1 Protein; Humans; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Resveratrol; Sirtuin 1; Up-Regulation | 2019 |
Protective effect of autologous transplantation of resveratrol preconditioned adipose-derived stem cells in the treatment of diabetic liver dysfunction in rat model.
Topics: Adipose Tissue; Animals; Apoptosis; Cell Survival; Clone Cells; Culture Media, Conditioned; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Liver; Liver Cirrhosis; Liver Diseases; Male; Protective Agents; Rats, Wistar; Resveratrol; Signal Transduction; Sirtuin 1; Stem Cell Transplantation; Stem Cells; Tissue Survival; Transplantation, Autologous | 2019 |
Effects of Piceatannol and Resveratrol on Sirtuins and Hepatic Inflammation in High-Fat Diet-Fed Mice.
Topics: Animals; Diet, High-Fat; Humans; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sirtuins; Stilbenes; Tumor Necrosis Factor-alpha | 2019 |
The adaptogenic anti-ageing potential of resveratrol against heat stress-mediated liver injury in aged rats: Role of HSP70 and NF-kB signalling.
Topics: Alkaline Phosphatase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Heat Stress Disorders; HSP70 Heat-Shock Proteins; Liver; Liver Diseases; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |
Preventive effects of resveratrol against azoxymethane induced damage in rat liver.
Topics: Animals; Antioxidants; Azoxymethane; Carcinogens; Female; Glutathione; Liver Diseases; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2013 |
Resveratrol, a natural antioxidant, has a protective effect on liver injury induced by inorganic arsenic exposure.
Topics: Animals; Antioxidants; Arsenic; Arsenic Trioxide; Arsenicals; Cats; Environmental Exposure; Glutathione; Liver; Liver Diseases; Malondialdehyde; Oxidative Stress; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2014 |
Resveratrol mediates therapeutic hepatic effects in acquired and genetic murine models of iron-overload.
Topics: Acetylation; Animals; Antioxidants; Apoptosis; Chronic Disease; Disease Models, Animal; Forkhead Box Protein O1; Forkhead Transcription Factors; Hemochromatosis; Iron; Iron Overload; Liver Diseases; Mice; Models, Genetic; Oxidative Stress; Resveratrol; Sirtuin 1; Stilbenes; Treatment Outcome | 2016 |
Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation.
Topics: Animals; Antioxidants; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytoprotection; Diet; Disease Models, Animal; Intubation, Gastrointestinal; Lipid Peroxidation; Liver; Liver Diseases; Male; Malondialdehyde; Plant Stems; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Vitis | 2009 |
Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Disease Models, Animal; Glutathione Peroxidase; Ligation; Liver; Liver Diseases; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes; Superoxide Dismutase | 2008 |
Resveratrol protects against irradiation-induced hepatic and ileal damage via its anti-oxidative activity.
Topics: Animals; Antioxidants; Apoptosis; Glutathione; Ileal Diseases; Ileum; Lipid Peroxidation; Liver; Liver Diseases; Liver Function Tests; Male; Peroxidase; Radiation Injuries, Experimental; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2009 |
FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states.
Topics: Acetylation; Animals; Dimerization; Disease Models, Animal; Down-Regulation; Hep G2 Cells; Histone Deacetylases; Liver; Liver Diseases; Male; Mice; Mutagenesis, Site-Directed; p300-CBP Transcription Factors; Protein Stability; Receptors, Cytoplasmic and Nuclear; Resveratrol; Retinoid X Receptor alpha; RNA, Small Interfering; Sirtuin 1; Stilbenes; Transcription Factors; Transcriptional Activation | 2009 |
Resveratrol and liver disease: from bench to bedside and community.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carbon Tetrachloride; Cytokines; Ethanol; Free Radicals; Glutathione; Hepatocytes; Humans; Liver Diseases; NF-kappa B; Resveratrol; Stilbenes | 2010 |
Heat stress-induced hepatotoxicity and its prevention by resveratrol in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Heat-Shock Response; Hot Temperature; Liver; Liver Diseases; Male; Oxidative Stress; Oxidoreductases; Rats; Rats, Wistar; Resveratrol; Stilbenes | 2011 |
Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Lipid Peroxidation; Lipids; Liver; Liver Diseases; Male; Malondialdehyde; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin | 2012 |
Prophylactic effect of resveratrol against ethinylestradiol-induced liver cholestasis.
Topics: Animals; Antioxidants; Bile Acids and Salts; Bilirubin; Cholestasis; Cholesterol; Ethinyl Estradiol; Female; Hepatocytes; Liver; Liver Diseases; Malondialdehyde; Nitric Oxide; Phytotherapy; Plant Extracts; Rats; Rats, Inbred Strains; Resveratrol; Stilbenes; Sulfhydryl Compounds; Tumor Necrosis Factor-alpha | 2013 |
[Protective effect of propofol and resveratrol pretreatment against hepatocyte apoptosis in rats with hepatic ischemia-reperfusion injury].
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Hepatocytes; Ischemic Preconditioning; Liver Diseases; Male; Propofol; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Resveratrol; Stilbenes | 2013 |
Effect of resveratrol on alcohol-induced mortality and liver lesions in mice.
Topics: Alanine Transaminase; Alcoholism; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Drinking; Eating; Interleukin-1; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Resveratrol; Stilbenes; Transaminases; Tumor Necrosis Factor-alpha | 2006 |
[Ideas, research and ethics of scientific journals].
Topics: Alcoholic Intoxication; Animals; Chemical and Drug Induced Liver Injury; Ethics, Professional; Liver Diseases; Mice; Parenteral Nutrition, Total; Periodicals as Topic; Professional Misconduct; Publishing; Research Support as Topic; Resveratrol; Stilbenes | 2007 |
Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat.
Topics: Acute Disease; Alanine Transaminase; Animals; Antioxidants; Carbon Tetrachloride Poisoning; Disease Models, Animal; gamma-Glutamyltransferase; Glutathione; Glutathione Disulfide; Lipid Peroxidation; Liver; Liver Diseases; Male; Methylation; Molecular Structure; Rats; Rats, Wistar; Resveratrol; Stilbenes; Structure-Activity Relationship | 2008 |